Roger L. Lundblad, Ph.D. has a background of more than 40 years in both academia and industry.
This experience provides a powerful background for service to in
the biotechnology industry. He was responsible for the development of a purification method for a leading biopharmaeeutical product and has developed and validated a number of assays used in biopharmaceutical manufacturing. His long tenure in scholarly activity provides major value for literature searching (you can't find everything on the computer). This has proved of particular value in protecting intellectual property. He also had editorial talent having served as Editor-in-Chief of two biotechnology journals as well as sole authorship of a number of books; He has also edited several books in the Fourth edition of the Handbook of Biochemistry and Molecular Biology.Biotechnology of Plasma Proteins is in press and expected in September, 2012. Biotechnology of the Extravascular Fluids is in the planning stages.
Dr. Lundblad Specializes in the following: